DVAX
Dynavax Technologies Corporation · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website dynavax.com
- Employees(FY) 351
- ISIN US2681582019
Performance
+0.91%
1W
-3.31%
1M
-10.48%
3M
-17.89%
6M
-20.53%
YTD
-0.18%
1Y
Profile
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
Investment Analysis Report: DVAX
Overview
DVAX is a biotechnology company operating in the Health Technology sector with a market capitalization of $1.6 billion. The company's financial data provides insights into its valuation, financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, and capital expen...
Technical Analysis of DVAX 2024-05-10
Overview:
In analyzing the technical indicators for DVAX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the c...
Recent News & Updates
- 2024-05-14 09:59
- 2024-05-14 08:30
- 2024-05-13 20:55
- 2024-05-13 20:30
- 2024-05-11 08:46
- 2024-05-10 13:43
- 2024-05-10 07:22
- 2024-05-09 13:58
- 2024-05-09 03:40
- 2024-05-09 02:15
- 2024-05-09 01:58
- 2024-05-08 17:20
- 2024-05-08 16:17
Dynavax Technologies: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-08 16:01
- 2024-05-08 08:59
- 2024-05-08 05:20
- 2024-05-08 04:01
- 2024-04-24 16:05
- 2024-04-24 04:05
- 2024-04-23 20:00
DVAX: What does Argus have to say about DVAX?(Argus Research)
- 2024-04-21 10:39
11 Best Low Price Pharma Stocks To Invest In(Insider Monkey)
- 2024-04-20 22:39
11 Best Low Price Pharma Stocks To Invest In(Insidermonkey)
- 2024-03-25 07:58
- 2024-03-04 23:53
- 2024-03-04 20:28
11 Best Small Cap Pharma Stocks to Invest In(Insider Monkey)
- 2024-03-04 07:28
11 Best Small Cap Pharma Stocks to Invest In(Insidermonkey)
- 2024-02-27 18:54
- 2024-02-27 05:54
- 2024-02-23 10:34
- 2024-02-23 06:38
Q4 2023 Dynavax Technologies Corp Earnings Call(Thomson Reuters StreetEvents)
Page 1 of 6
previousnext